StockTipsArenaBeta

BUY Kopran Limited — Rakesh Bansal

BUYKopran Limited
Kopran share price target & all analyst calls

byRakesh BansalHorizon: 1–3 months13 Nov 2026via CNBC Awaaz.

Entry₹287Inferred
Target₹335
Total upside +16.72%
Stop loss₹260-9.41% risk
CMP₹289.071d ago
Active+0.72%+15.89%upside left 3 mo left
Follow Rakesh Bansal for new calls(38% target hit, 34 closed calls)Get alertsWatch KOPRAN for new buy/sell callsGet alertsSee 83 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:24 am IST
3 supporting2 neutral1 opposing
Supports the BUY call (3)

MACD above its signal line — bullish momentum

Technicals · macd·14 Nov · today

Kopran promoter group stake rises to 6.36% via market purchase

NewsGoogle News·13 Nov · yesterday

(opens in new tab)

The European Union's Medicine Authority has successfully concluded a Good Manufacturing Practice (GMP) inspection at the company's formulation facility in Khopoli.

BSE · Company Update·22 Oct · 3w ago

(opens in new tab)
Neutral / worth noting (2)

Kopran Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·3 Nov · 2w ago

(opens in new tab)

Unaudited Results for Q2 FY 2026-27

BSE · Board Meeting·3 Nov · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

RSI at 75 — overbought territory

Technicals · rsi·14 Nov · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Kopran

All analyst calls on Kopran

More from Rakesh Bansal

Every call and its outcome